(Q41172466)

27 September 2017

1 reference

title

Early detection of Parkinson's disease. Implications for treatment (English)

1 reference

27 September 2017

1 reference

1

Rocco Paola

1 reference

27 September 2017

2

Ryan J. Uitti

1 reference

27 September 2017

1 September 1996

1 reference

27 September 2017

1 reference

27 September 2017

9

1 reference

27 September 2017

3

1 reference

27 September 2017

159-168

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199609030-00002

27 September 2017

0 references

cites work

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

1 reference

12 December 2020

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

1 reference

12 December 2020

The occurrence of motor fluctuations in parkinsonian patients treated long term with levodopa: role of early treatment and disease progression

1 reference

12 December 2020

Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients

1 reference

12 December 2020

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

1 reference

12 December 2020

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

12 December 2020

123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism

1 reference

12 December 2020

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence

1 reference

12 December 2020

Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.

1 reference

12 December 2020

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

1 reference

12 December 2020

Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes.

1 reference

12 December 2020

Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties

1 reference

12 December 2020

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

12 December 2020

Multi-center study of Parkinson mortality with early versus later dopa treatment

1 reference

12 December 2020

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

1 reference

12 December 2020

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project

1 reference

12 December 2020

Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.

1 reference

12 December 2020

Dopamine is a monoamine oxidase B substrate in man.

1 reference

12 December 2020

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

12 December 2020

A controlled trial of lazabemide (RO19-6327) in untreated Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

1 reference

12 December 2020

Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group

1 reference

12 December 2020

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

12 December 2020

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

1 reference

12 December 2020

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

1 reference

12 December 2020

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group

1 reference

12 December 2020

"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

1 reference

12 December 2020

PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease

1 reference

12 December 2020

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

12 December 2020

Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage?

1 reference

12 December 2020

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

1 reference

12 December 2020

Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

1 reference

12 December 2020

[123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.

1 reference

12 December 2020

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

1 reference

12 December 2020

Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?

1 reference

12 December 2020

Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging

1 reference

12 December 2020

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

1 reference

12 December 2020

The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa

1 reference

12 December 2020

The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred

1 reference

12 December 2020

Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization

1 reference

12 December 2020

Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications?

1 reference

12 December 2020

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

1 reference

12 December 2020

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

12 December 2020

Mitochondrial DNA analysis in Parkinson's disease

1 reference

12 December 2020

Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors

1 reference

12 December 2020

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

12 December 2020

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.

1 reference

12 December 2020

Early combination therapy with bromocriptine and levodopa in Parkinson's disease

1 reference

12 December 2020

Selegiline can mediate neuronal rescue rather than neuronal protection

1 reference

12 December 2020

Treatment of Parkinson's disease with pergolide: a double-blind study

1 reference

12 December 2020

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

12 December 2020

The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic

1 reference

12 December 2020

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

12 December 2020

Effect of intracerebroventricular infusion of epidermal growth factor in rats hemitransected in the nigro-striatal pathway.

1 reference

12 December 2020

10.2165/00002512-199609030-00002

Identifiers

DOI

1 reference

PubMed ID

8877310

Dimensions Publication ID

27 September 2017

0 references

1 reference

PubMed ID

8877310